DAEWOONG CO., LTD.; LTD.;재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소;DAEWOONG CO.;(주)시지바이오;CG BIO CO., LTD.;UTAH-INHA DDS & ADVANCED THERAPEUTICS RESEARCH CENTER;주식회사 대웅
发明人:
KIM, IN AE,김인애,KIM, SANG HEE,김상희,JUNG, JI HOON,정지훈,CHANG, HEE CHUL,장희철,MAENG, JIN HEE,맹진희,YANG, SU GEUN,양수근,LEE, DON HAENG,이돈행,MIN, KYUNG HYUN,민경현,KIM, IN AEKR,KIM, SANG HEEKR,JUNG, JI HOONKR,CHANG, HEE CHULKR,MAENG, JIN HEEKR,YANG, SU GEUNKR,LEE, DON HAENGKR,MIN, KYUNG HYUNKR
申请号：
KR1020130131181
公开号：
KR1020140098656A
申请日:
2013.10.31
申请国别(地区):
KR
年份:
2014
代理人:
摘要：
The present invention provides a pharmaceutical composition for protecting wounds, preventing hemorrhage, or preventing adhesion in a gastrointestinal tract. The composition includes a polymer which is adhesive to a specific mucous membrane, and includes a specific absorbent. In particular, the polymer adhesive to a specific mucous membrane comprises one or more selected from a group consisting of hydroxyethyl cellulose and polyethylene oxide. The absorbent comprises one or more selected from a group consisting of croscarmellose sodium, sodium starch glycolate, and crospovidone.The pharmaceutical composition is in the form of powder.본 발명은 특정 점막 부착성 중합체； 및 특정 흡습제를 포함하는, 분말 형태의 위장관 내 상처 보호, 출혈 방지, 또는 유착 방지용 약학 조성물을 제공한다.
